Breistøl, K <br/><br/>
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Sep 1998 
 - 1602-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(98)00152-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Small Cell--drug therapy<br/>Cell Division--drug effects<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--analogs & derivatives<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Prodrugs--therapeutic use<br/>Transplantation, Heterologous